AI-Powered ultrasound training could save lives in cardiac arrest

NCT ID NCT06567912

Recruiting now Knowledge-focused Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing a new training program that teaches doctors how to use a special ultrasound (TEE) during cardiac arrest. The program includes a lecture and hands-on practice with a simulator. Researchers are also developing an AI tool to assess how well doctors perform. The goal is to see if this training helps doctors get better at using ultrasound, which could lead to faster and more accurate treatment for patients in cardiac arrest. The study involves 100 junior doctors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TEE simulation curriculum (lecture and hands-on training on a simulation model)
What this could lead to: If successful, this could improve how quickly and accurately doctors use ultrasound during cardiac arrest, potentially leading to better patient outcomes.
What could go wrong: This is a small, early-stage educational study focused on training, not a direct treatment. The AI tool may not work perfectly in real emergencies, and better training does not guarantee better survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OUT-OF-HOSPITAL CARDIAC ARREST are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac arrest Out-of-Hospital Cardiac Arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OUT-OF-HOSPITAL CARDIAC ARREST

Contacts and locations

Locations

Lien
RECRUITING

Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.